These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6156472)

  • 1. Zinc tannate salts of heroin, LAAM and hydromorphone attenuate opiate withdrawal syndrome.
    Brands B; Baskerville JC; Hirst M; Gowdey CW
    Psychopharmacology (Berl); 1980; 68(3):311-4. PubMed ID: 6156472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence in rats after one injection of heroin-, LAAM- or hydromorphone-zinc tannate.
    Brands B; Baskerville JC; Hirst M; Gowdey CW
    Pharmacol Biochem Behav; 1979 Sep; 11(3):279-82. PubMed ID: 92035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response analysis of opioid cross-tolerance and withdrawal suppression during LAAM maintenance.
    Houtsmuller EJ; Walsh SL; Schuh KJ; Johnson RE; Stitzer ML; Bigelow GE
    J Pharmacol Exp Ther; 1998 May; 285(2):387-96. PubMed ID: 9580575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats.
    Newman JL; Vann RE; May EL; Beardsley PM
    Psychopharmacology (Berl); 2002 Oct; 164(1):108-14. PubMed ID: 12373424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. l-alpha-Acetylmethadol, l-alpha-acetyl-N-normethadol and l-alpha-acetyl-N,N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dog.
    Vaupel DB; Jasinski DR
    J Pharmacol Exp Ther; 1997 Nov; 283(2):833-42. PubMed ID: 9353405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-alpha-acetylmethadol (LAAM), methadone and morphine abstinence in dependent rats: EEG and behavioral correlates.
    Young GA; Moreton JE; Meltzer LT; Khazan N
    Drug Alcohol Depend; 1977 Mar; 2(2):141-8. PubMed ID: 192530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma testosterone and luteinizing hormone levels during levo-alpha-acetylmethadol maintenance and withdrawal.
    Mendelson JH; Ellingboe J; Judson BA; Goldstein A
    Clin Pharmacol Ther; 1984 Apr; 35(4):545-7. PubMed ID: 6705455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of levo-alpha-acetylmethadol (LAAM) on morphine self-administration in the rat.
    Lukas SE; Moreton JE; Khazan N
    Psychopharmacology (Berl); 1981; 73(1):12-6. PubMed ID: 6785783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early clinical studies of levo-alpha acetylmethadol (LAAM): an opiate for use in the medical treatment of chronic heroin dependence.
    Blaine JD
    NIDA Res Monogr; 1978; (19):249-59. PubMed ID: 106289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narcotic abstinence in dependent rats: EEG and behavioral correlates.
    Young GA; Steinfels GF; Khazan N
    Pharmacol Biochem Behav; 1980 Jul; 13(1):115-9. PubMed ID: 7190706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-tolerance and mu agonist efficacy in pigeons treated with LAAM or buprenorphine.
    Galici R; McMahon LR; France CP
    Pharmacol Biochem Behav; 2005 Jul; 81(3):626-34. PubMed ID: 15946731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of levo-alpha-acetylmethadol and its metabolites on schedule-controlled behavior in the pigeon.
    McGivney WT; McMillan DE
    J Pharmacol Exp Ther; 1981 Feb; 216(2):299-305. PubMed ID: 7463351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine challenges in levo-alpha-acetylmethadol (LAAM) post-addict rats.
    Young GA; Wolf DL; Steinfels GF; Khazan N
    Life Sci; 1981 Mar; 28(13):1523-7. PubMed ID: 7195447
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal levo-alpha-acetylmethadol (LAAM) and/or naloxone: effects on brain chemistry and postweaning behavior.
    Lichtblau L; Sparber SB
    Neurobehav Toxicol Teratol; 1983; 5(4):479-86. PubMed ID: 6196651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical experience with LAAM.
    Goldstein A
    NIDA Res Monogr; 1976 Jul; (8):115-7. PubMed ID: 995176
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).
    Tennant FS; Rawson RA; Pumphrey E; Seecof R
    J Subst Abuse Treat; 1986; 3(3):195-202. PubMed ID: 3806733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous vs. naloxone-induced abstinence in dependent rats self-administering L-alpha-acetylmethadol (LAAM) or morphine.
    Young GA; Steinfels GF; Khazan N
    Pharmacol Biochem Behav; 1979 Apr; 10(4):585-9. PubMed ID: 223173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of chronic oral administration of levo-alpha-acetylmethadol in the rat.
    Agner TG; Balster RL
    Pharmacol Biochem Behav; 1978 May; 8(5):593-6. PubMed ID: 674263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic l-alpha acetylmethadol in rhesus monkeys: discriminative stimulus and other behavioral measures of dependence and withdrawal.
    Brandt MR; France CP
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1029-37. PubMed ID: 9864289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.